サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1375195

アジア太平洋地域のバイオプロセス技術市場の2028年までの予測- タイプ、モダリティ、エンドユーザー別の地域分析

Asia Pacific Bioprocess Technology Market Forecast to 2028 - Regional Analysis By Type, Modality, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 141 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
アジア太平洋地域のバイオプロセス技術市場の2028年までの予測- タイプ、モダリティ、エンドユーザー別の地域分析
出版日: 2023年09月14日
発行: The Insight Partners
ページ情報: 英文 141 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域のバイオプロセス技術市場は、2023年の46億864万米ドルから2028年には110億75万米ドルに成長すると予測されています。2023年から2028年までのCAGRは19.0%と推定されます。

自動リアルタイムフローサイトメトリー（ART-FCM）の登場がアジア太平洋のバイオプロセス技術市場を牽引

フローサイトメトリー（FCM）とその技術的可能性は、バイオリアクターにおける単一細胞の特性や異なる細胞種の集団分布の分析ツールとして、過去10年間に大きく進歩しました。その過程で、オペレーターの干渉を受けずに、サンプリング頻度を変えながら長期間にわたってバイオリアクターのプロセスをモニタリングする自動リアルタイム・フローサイトメトリー（ART-FCM）ソリューションがいくつか開発されました。ART-FCMは、バイオプロセスにおける重要なイベントを見逃すことなく長期間の測定を可能にし、未知の可能性が高く、より詳細に調査されるべき時間的現象を発見します。また、より頻繁な測定も、人員の都合に左右されることなく、ユーザーが定義した頻度で行うことができます。オミクスのような単一細胞レベルでは部分的にしか利用できない手法と比較すると、ART-FCMを利用することで、労力と時間を費やすことなく、マルチパラメーター測定を容易に確立することができます。従来のFCM研究と比較して、マイクロ流体デバイスはチップ上のART-FCMとして大きな将来性を持っています。この文脈では、異なるバイオリアクターまたはバイオリアクターセットアップ内の異なる場所からのサンプルを同時に分析できるため、並列化がより重要になるかもしれないです。また、蛍光プロセスパラメーターの高速で再現性の高いリアルタイムモニタリングが求められる他の実験セットアップにも、多くの側面が適応できるかもしれないです。結論として、ART-FCMは今後数年で飛躍的に進歩すると思われます。

アジア太平洋バイオプロセス技術市場概要

BioPlan Associatesの「Top 1000 Biofacility Index and Biomanufacturers Database」レポートによると、世界のバイオプロセス生産能力は過去10年間平均12％増加しています。中国は、低分子医薬品と高分子医薬品の市場参入企業として、それぞれ世界第2位と第3位を占めています。また、中国は開発製造受託機関（CDMO）の拠点であり、国内のバイオ生産能力の25％を占めているため、細胞治療や遺伝子治療の開発企業がいくつも存在します。そのため、中国にはかなりのバイオ製造能力があるが、生物製剤の安全性と有効性に対する信頼を築く世界のGMP基準を厳格に遵守しています。

アジア太平洋地域のバイオプロセス技術市場の収益と2028年までの予測（金額）

アジア太平洋地域のバイオプロセス技術市場のセグメンテーション

アジア太平洋のバイオプロセス技術市場は、タイプ、モダリティ、エンドユーザー、国に区分されます。

タイプ別では、アジア太平洋のバイオプロセス技術市場は、細胞培養培地バイオプロセス、クロマトグラフィーバイオプロセス、消耗品＆アクセサリー、その他に区分されます。2023年には、消耗品＆アクセサリー分野がアジア太平洋のバイオプロセス技術市場で最大のシェアを記録しました。

アジア太平洋のバイオプロセス技術市場は、モダリティに基づいて、シングルユースとマルチユースに二分されます。2023年、アジア太平洋のバイオプロセス技術市場では、単一用途分野がより大きなシェアを記録しました。

アジア太平洋のバイオプロセス技術市場は、最終用途に基づき、学術・医療機関、バイオ製薬会社、研究所、その他に区分されます。2023年には、バイオ製薬会社セグメントがアジア太平洋バイオプロセス技術市場で最大のシェアを記録しました。

国別では、アジア太平洋バイオプロセス技術市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2023年には、中国セグメントがアジア太平洋のバイオプロセス技術市場で最大のシェアを記録しました。

Corning Inc、Danaher Corp、Eppendorf SE、Lonza Group AG、Merck KGaA、Repligen Corp、Sartorius AG、およびThermo Fisher Scientific Incは、アジア太平洋バイオプロセス技術市場で事業展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 アジア太平洋のバイオプロセス技術市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域のバイオプロセス技術市場- 市場情勢

  • アジア太平洋地域のPEST分析
  • 専門家の見解

第5章 アジア太平洋地域のバイオプロセス技術市場：主要市場力学

  • 市場促進要因
    • 新薬開発のための研究開発費の増加
    • 慢性疾患の増加
  • 市場抑制要因
    • 厳しい規制政策
  • 市場機会
    • 先進バイオプロセス技術の導入
  • 今後の動向
    • 自動リアルタイムフローサイトメトリー（ART-FCM）の登場
  • 影響分析

第6章 バイオプロセス技術市場：アジア太平洋地域の分析

  • アジア太平洋地域のバイオプロセス技術市場の収益予測と分析

第7章 アジア太平洋のバイオプロセス技術市場-2028年までの収益と予測-タイプ別

  • バイオプロセス技術市場の2022年・2028年タイプ別収益シェア（%）
  • 細胞培養培地バイオプロセス
  • クロマトグラフィーバイオプロセス
  • 消耗品・アクセサリー
  • その他

第8章 アジア太平洋地域のバイオプロセス技術市場の分析と2028年までの予測：モダリティ別

  • アジア太平洋地域のバイオプロセス技術市場：モダリティ別2022年・2028年（%）
  • シングルユース
  • 複数用途

第9章 アジア太平洋地域のバイオプロセス技術市場：収益と2028年までの予測：エンドユーザー別

  • アジア太平洋バイオプロセス技術市場：2022年および2028年エンドユーザー別売上高シェア（%）
  • 学術・医療機関
  • バイオ医薬品企業
  • 研究機関
  • その他

第10章 アジア太平洋地域のバイオプロセス技術市場：収益と2028年までの予測：国別分析

    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域

第11章 アジア太平洋地域のバイオプロセス技術市場：業界情勢

  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Bioprocess Technology Market, Revenue and Forecast, 2020-2028 (US$ Million)
  • Table 2. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 21. Recent Inorganic Growth Strategies in the Asia Pacific bioprocess technology market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Bioprocess Technology Market Segmentation
  • Figure 2. Asia Pacific Bioprocess Technology Market, by Country
  • Figure 3. Asia Pacific Bioprocess Technology Market Overview
  • Figure 4. Others Segment Held Largest Share of Type Segment in Asia Pacific Bioprocess Technology Market
  • Figure 5. India Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Asia Pacific Bioprocess Technology Market Impact and Analysis
  • Figure 9. Asia Pacific Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 11. Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Chromatographic Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 16. Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 19. Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028868

The Asia Pacific bioprocess technology market is expected to grow from US$ 4,608.64 million in 2023 to US$ 11,000.75 million by 2028. It is estimated to grow at a CAGR of 19.0% from 2023 to 2028.

Emergence of Automated Real-Time Flow Cytometry (ART-FCM) Drive Asia Pacific Bioprocess Technology Market

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated Real-Time Flow Cytometry (ART-FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency. ART-FCM enables s long-term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM. Compared with conventional FCM studies, microfluidic devices great future potential as ART-FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real-time monitoring of fluorescent process parameters is also of interest. In conclusion, ART-FCM will most probably advance exponentially in the upcoming years.

Asia Pacific Bioprocess Technology Market Overview

The bioprocessing capacity globally has increased at an average of 12% since the past decade, as per the BioPlan Associates Top 1000 Biofacility Index and Biomanufacturers Database report. China is well positioned as a global participant in markets with both small and large-molecule drugs, accounting for second and third position, respectively, worldwide. Also, China is home to several developers of cell and gene therapy due to China's base for contract development and manufacturing organizations (CDMOs), accounting for ~25% of the country's bioproduction capacity. Therefore, China has considerable biomanufacturing capabilities but strict adherence to the global GMP standards that build confidence in the biologics' safety and effectiveness.

Asia Pacific Bioprocess Technology Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Bioprocess Technology Market Segmentation

The Asia Pacific bioprocess technology market is segmented into type, modality, end user, and country.

Based on type, the Asia Pacific bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. In 2023, the consumables & accessories segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on modality, the Asia Pacific Bioprocess technology market is bifurcated into single use and multiple use. In 2023, the single use segment registered a larger share in the Asia Pacific bioprocess technology market.

Based on end-use, the Asia Pacific Bioprocess technology market is segmented into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. In 2023, the biopharmaceutical companies segment registered the largest share in the Asia Pacific bioprocess technology market.

Based on country, the Asia Pacific Bioprocess technology market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. In 2023, China segment registered a largest share in the Asia Pacific bioprocess technology market.

Corning Inc; Danaher Corp; Eppendorf SE; Lonza Group AG; Merck KGaA; Repligen Corp; Sartorius AG; and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific bioprocess technology market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioprocess technology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Bioprocess Technology Market - by Type
    • 1.3.2 Asia Pacific Bioprocess Technology Market - by Modality
    • 1.3.3 Asia Pacific Bioprocess Technology Market - by End User
    • 1.3.4 Asia Pacific Bioprocess Technology Market - by Country

2. Asia Pacific Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Emergence of Automated Real-Time Flow Cytometry (ART-FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Bioprocess Technology Market Revenue Forecast and Analysis

7. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatography Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatography Bioprocess: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Asia Pacific Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.1.1.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Bioprocess Technology Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sartorius AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Thermo Fisher Scientific Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Corning Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lonza Group AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Repligen Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Danaher Corp
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms